[ad_1] Eli Lilly’s Mounjaro is significantly more effective than Novo Nordisk’s Ozempic in producing weight…
NVO
-
-
[ad_1] Medicare’s decades-old exclusion of weight-loss drug coverage is coming under scrutiny amid mounting evidence…
-
STOCK MARKET
Morgan Stanley has boosted its S&P 500 target — but here’s where it sees the real opportunities
by userby user[ad_1] The big news over the weekend for financial markets was, of course, MarketWatch 50…
-
STOCK MARKET
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
by userby user[ad_1] Novo Nordisk’s popular weight-loss drug Wegovy significantly cut the risk of heart attack, stroke or…
-
STOCK MARKET
Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan
by userby user[ad_1] Let’s hear it for retail investors, who don’t get enough credit for taking care…
-
STOCK MARKET
What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.
by userby user[ad_1] What exactly are people taking the new class of weight-loss drugs eating and what…
-
[ad_1] The U.S. Patent and Trademark Office’s patent trial and appeal board has agreed to…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby user[ad_1] All of the primary manufacturers of the 10 drugs selected in August for Medicare…
-
STOCK MARKET
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
by userby user[ad_1] Medicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation…
-
STOCK MARKET
Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
by userby user[ad_1] Novo Nordisk’s U.S.-listed stock jumped rose 13% early Tuesday, after the company said its…